Publication November 12, 2026

LL-37 Featured in New Study on Diabetic Foot Infections

A new publication involving LL-37 was released on November 12, 2026. The study, titled "Serum vitamin D, innate immunity markers, and biofilm presence as determinants of therapeutic strategies in diabetic foot infections: A comparative cross-sectional study," appeared in the journal Nutrition and Health.

LL-37 is referenced in the paper as part of innate immunity markers studied alongside serum vitamin D and biofilm presence in the context of diabetic foot infections. The publication is described as a comparative cross-sectional study, indicating it compared data across different patient groups at a single point in time.

LL-37 remains classified as an unapproved compound used in research settings. No findings, outcomes, or conclusions from this study are detailed here beyond its title and publication venue.

Readers interested in this topic can consult the original publication listed in the source link for full study details and any reported outcomes.

For additional background on this compound, see the LL-37 overview page.

See the full ll-37 overview

Source: https://pubmed.ncbi.nlm.nih.gov/43017885/